All
Unstoppable analysis of pesticides residues in black tea
September 26th 2024In this study, the suitability of the TSQ 9610 triple quadrupole GC-MS/MS system was assessed for the analysis of more than 200 pesticides in black tea at trace concentrations supplemented with SPE cleanup. The linearity, accuracy, precision, limit of quantitation, and injection reproducibility of 20 selected analytes representative of the different pesticide classes in black tea matrix are demonstrated.
Quantitative analysis of environmental contaminants using Orbitrap Exploris GC
September 26th 2024The benefits of the Thermo Scientific™ Orbitrap Exploris™ GC mass spectrometer system for the analysis of trace level contaminants, such as pesticides, polychlorinated biphenyls (PCBs), polycyclic aromatic hydrocarbons (PAHs), and brominated flame retardants (BFRs) are showcased.
Meeting System Suitability for USP Abacavir and Lamivudine Tablets Assay
September 23rd 2024Abacavir and Lamivudine in combination are used with other medications to treat Human Immunodeficiency Virus (HIV) infection. In this technical note, we report the separation of Lamivudine from its related chiral and diastereomeric impurities in Abacavir and Lamivudine tablets per the USP monograph. The allowable adjustments pertaining to gradient separations are highlighted together with the necessary calculations that are required for the adjusted method conditions to remain compliant with the original monograph.
Nitrosamines, Meeting Regulatory Requirements
September 23rd 2024The necessity to analyse drug products for nitrosamines and NDSRIs (Nitrosamine Drug Substance Related Impurities) is well documented. In this document we provide an overview of 7 of our most recent applications in this area, together with links to the relevant technical notes.
Glucagon-Like-Peptide-1 (GLP-1) Analogues Applications Notebook
September 23rd 2024This applications notebook provides background information on GLP-1 analogues, together with information on the columns suitable for their purification and analysis. Finally it provides a range of reversed phase, size exclusion and preparative applications for a number of GLP-1 analogues.
Demystifying L/dp Ratio When Working with Allowable Adjustments
September 23rd 2024This white paper explores L/dp ratio for pharmacopeia allowable adjustments. It considers efficiency, explaining why L/dp ratio can be used as a proxy for efficiency, and illustrates the allowable adjustments through reviewing at a selection of different monographs.
Reliable and Objective Antibody Analysis with the New Agilent ProteoAnalyzer System
September 18th 2024This technical overview compares the characterization of NISTmAb using the ProteoAnalyzer with published NIST data obtained via traditional single capillary CE-SDS technology. The results show strong correlation with the reference data, confirming that the ProteoAnalyzer is a reliable tool for analytical workflows.